BEGIN:VCALENDAR
PRODID:-//Bizzabo//EN
VERSION:2.0
BEGIN:VEVENT
UID:event-226401@bizzabo.com
ORGANIZER;CN="LSPN Connect":mailto:lmcmillan@newtonmedia.co.uk
DTSTAMP:20260726T001811Z
DTSTART:20220101T000000Z
DTEND:20231231T151500Z
SUMMARY:LSPN Connect
DESCRIPTION:Life sciences innovators at all stages seek patent protectio
 n to limit market competition and, in some cases, attract fu
 rther investment. Careful IP planning is especially importan
 t in the life sciences, with many companies relying on a han
 dful of patents to protect their high-value products. It is 
 essential that companies pay close attention to the interrel
 ationship between patent and US Food and Drug Administration
  (FDA) regulatory considerations to protect their most valua
 ble assets for the long term.\n\nThis program will provide a
 n overview of the interplay between patent and FDA strategy 
 for pharmaceutical patents, including:\n\n- Strategies for o
 btaining strong patent protection for small molecule and bio
 logics drugs\n- Maximising patent term through Patent Term A
 djustment (PTA) and Patent Term Extension (PTE)\n- FDA regul
 atory exclusivities\n- Orange Book vs Purple Book patent lis
 tings\n- Due diligence considerations\n\nhttps://www.lspncon
 nect.com/agenda
LOCATION:London
END:VEVENT
END:VCALENDAR